Figure 4

Representation of VH family frequency usage by BP180-specific IgM (panel A) or IgG (panel B) circulating B cells from BP patients before (medium-blue column) or after (light-blue column) rituximab treatment at different time points D360, D540 and D720, compared with non-autoreactive B cells from healthy individuals (white column) (Fisher exact test).